JP2011516041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516041A5 JP2011516041A5 JP2010550830A JP2010550830A JP2011516041A5 JP 2011516041 A5 JP2011516041 A5 JP 2011516041A5 JP 2010550830 A JP2010550830 A JP 2010550830A JP 2010550830 A JP2010550830 A JP 2010550830A JP 2011516041 A5 JP2011516041 A5 JP 2011516041A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibodies
- seq
- tyrp1
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6919908P | 2008-03-12 | 2008-03-12 | |
| US61/069,199 | 2008-03-12 | ||
| PCT/US2009/036739 WO2009114585A1 (en) | 2008-03-12 | 2009-03-11 | Anti-tyrp1 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011516041A JP2011516041A (ja) | 2011-05-26 |
| JP2011516041A5 true JP2011516041A5 (https=) | 2014-03-06 |
Family
ID=40790741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010550830A Pending JP2011516041A (ja) | 2008-03-12 | 2009-03-11 | 抗ｔｙｒｐ１抗体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7951370B2 (https=) |
| EP (1) | EP2268672A1 (https=) |
| JP (1) | JP2011516041A (https=) |
| KR (1) | KR101203777B1 (https=) |
| CN (1) | CN101970500B (https=) |
| AR (1) | AR070821A1 (https=) |
| AU (1) | AU2009222998B2 (https=) |
| BR (1) | BRPI0909633A2 (https=) |
| CA (1) | CA2718289A1 (https=) |
| CL (1) | CL2009000567A1 (https=) |
| EA (1) | EA019517B1 (https=) |
| IL (1) | IL207581A0 (https=) |
| MX (1) | MX2010010021A (https=) |
| NZ (1) | NZ587305A (https=) |
| PE (1) | PE20091679A1 (https=) |
| TW (1) | TWI384997B (https=) |
| UA (1) | UA99339C2 (https=) |
| WO (1) | WO2009114585A1 (https=) |
| ZA (1) | ZA201006099B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5512514B2 (ja) * | 2007-06-29 | 2014-06-04 | エフ．ホフマン−ラ ロシュ アーゲー | 改善された免疫グロブリンの産生をもたらす重鎖変異体 |
| SG11201606439VA (en) | 2014-02-07 | 2016-09-29 | Dong Wha Pharm Co Ltd | Anticancer adjuvant composition containing rip3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting rip3 expression, and method for monitoring sensitivity of anticancer drug |
| EP3233907B1 (en) | 2014-12-19 | 2021-03-03 | Genmab A/S | Rodent bispecific heterodimeric proteins |
| RU2630647C1 (ru) * | 2016-05-27 | 2017-09-11 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО К КОНФОРМАЦИОННОМУ ЭПИТОПУ С3 КОМПОНЕНТА КОМПЛЕМЕНТА ЧЕЛОВЕКА, ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК (ВАРИАНТЫ), ЭКСПРЕССИОННЫЙ ВЕКТОР, СОДЕРЖАЩИЙ ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК (ВАРИАНТЫ), И ШТАММ КЛЕТОК ЯИЧНИКОВ КИТАЙСКОГО ХОМЯЧКА CHO-humC34-ПРОДУЦЕНТ ДАННОГО ГУМАНИЗИРОВАННОГО АНТИТЕЛА |
| GB201613167D0 (en) | 2016-07-29 | 2016-09-14 | Univ Southampton | Cancer and b-cell related disease therapy |
| WO2018075586A1 (en) * | 2016-10-18 | 2018-04-26 | Memorial Sloan-Kettering Cancer Center | Antigen-binding proteins targeting melanoma differentiation antigens and uses thereof |
| CN111032076A (zh) * | 2017-06-14 | 2020-04-17 | 阿迪塞特生物公司 | 能够以hla限制性方式结合hla-a2/tyrd的抗体及其用途 |
| RU2687609C1 (ru) * | 2018-05-30 | 2019-05-15 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства | Гуманизированное антитело к конформационному эпитопу сз компонента комплемента человека |
| IL281428B2 (en) | 2018-09-27 | 2024-10-01 | Autolus Ltd | Chimeric antigen receptor |
| US12371507B2 (en) | 2018-11-09 | 2025-07-29 | Beth Israel Deaconess Medical Center | CDCP1 antibodies and antibody drug conjugates |
| CR20210330A (es) * | 2018-12-21 | 2021-07-20 | Hoffmann La Roche | ANTICUERPOS QUE SE UNEN A CD3 (Divisional 2021-0325) |
| KR20220077127A (ko) * | 2019-09-06 | 2022-06-08 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | 암 치료를 위한 키메라 항원 수용체 및 관련 방법 및 조성물 |
| EP4121454A1 (en) * | 2020-03-19 | 2023-01-25 | Imperial College Innovations Limited | Coronavirus antibody |
| EP4437006A1 (en) * | 2021-11-26 | 2024-10-02 | F. Hoffmann-La Roche AG | Combination therapy of anti-tyrp1/anti-cd3 bispecific antibodies and tyrp1-specific antibodies |
| WO2025104289A1 (en) | 2023-11-17 | 2025-05-22 | Medincell S.A. | Antineoplastic combinations |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4798790A (en) * | 1985-07-18 | 1989-01-17 | Sloan-Kettering Institute | Monoclonal antibody specific for a pigmentation associated antigen |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| ATE243754T1 (de) | 1987-05-21 | 2003-07-15 | Micromet Ag | Multifunktionelle proteine mit vorbestimmter zielsetzung |
| IL89489A0 (en) | 1988-03-09 | 1989-09-10 | Hybritech Inc | Chimeric antibodies directed against human carcinoembryonic antigen |
| WO1989009622A1 (en) | 1988-04-15 | 1989-10-19 | Protein Design Labs, Inc. | Il-2 receptor-specific chimeric antibodies |
| ES2070172T3 (es) | 1988-04-16 | 1995-06-01 | Celltech Ltd | Procedimiento para producir proteinas mediante adn recombinante. |
| IE910820A1 (en) * | 1990-03-22 | 1991-09-25 | Sloan Kettering Inst Cancer | Gp75 as a tumor vaccine for melanoma |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| AU4025193A (en) | 1992-04-08 | 1993-11-18 | Cetus Oncology Corporation | Humanized C-erbB-2 specific antibodies |
| WO1996040249A1 (en) * | 1995-06-07 | 1996-12-19 | Sloan-Kettering Institute For Cancer Research | Therapeutic uses of ta99 |
| US5840839A (en) | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| IL136114A0 (en) * | 1997-11-14 | 2001-05-20 | Euro Celtique Sa | Immunoglobulin molecules having a synthetic variable region and modified specificity |
| IL152804A0 (en) * | 2000-05-16 | 2003-06-24 | Bolder Biotechnology Inc | Methods for refolding proteins containing free cysteine residues |
| AU2005299716B2 (en) * | 2004-10-22 | 2012-09-06 | Amgen Inc. | Methods for refolding of recombinant antibodies |
-
2009
- 2009-03-11 US US12/401,800 patent/US7951370B2/en not_active Expired - Fee Related
- 2009-03-11 CN CN2009801085150A patent/CN101970500B/zh not_active Expired - Fee Related
- 2009-03-11 PE PE2009000356A patent/PE20091679A1/es not_active Application Discontinuation
- 2009-03-11 UA UAA201010912A patent/UA99339C2/ru unknown
- 2009-03-11 KR KR1020107020296A patent/KR101203777B1/ko not_active Expired - Fee Related
- 2009-03-11 EA EA201071068A patent/EA019517B1/ru not_active IP Right Cessation
- 2009-03-11 AU AU2009222998A patent/AU2009222998B2/en not_active Ceased
- 2009-03-11 BR BRPI0909633A patent/BRPI0909633A2/pt not_active IP Right Cessation
- 2009-03-11 NZ NZ587305A patent/NZ587305A/en not_active IP Right Cessation
- 2009-03-11 WO PCT/US2009/036739 patent/WO2009114585A1/en not_active Ceased
- 2009-03-11 AR ARP090100858A patent/AR070821A1/es not_active Application Discontinuation
- 2009-03-11 JP JP2010550830A patent/JP2011516041A/ja active Pending
- 2009-03-11 TW TW098107909A patent/TWI384997B/zh not_active IP Right Cessation
- 2009-03-11 CA CA2718289A patent/CA2718289A1/en not_active Abandoned
- 2009-03-11 EP EP09719438A patent/EP2268672A1/en not_active Withdrawn
- 2009-03-11 MX MX2010010021A patent/MX2010010021A/es active IP Right Grant
- 2009-03-11 CL CL2009000567A patent/CL2009000567A1/es unknown
-
2010
- 2010-08-12 IL IL207581A patent/IL207581A0/en unknown
- 2010-08-26 ZA ZA2010/06099A patent/ZA201006099B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011516041A5 (https=) | ||
| EP3683239B1 (en) | Antibodies binding human claudin 18.2 and uses thereof | |
| TWI384997B (zh) | 抗酪胺酸酶相關蛋白-１（ｔｙｒｐ１）抗體 | |
| JP7575102B2 (ja) | Ｍｕｃ１８に特異的な抗体 | |
| CN105968206B (zh) | 抗erbb3抗体 | |
| JP2021531826A (ja) | 栄養膜細胞表面抗原２（ｔｒｏｐ２）に対する特異的な抗体 | |
| EP4166196A1 (en) | Antibodies binding cd24, preparation and use thereof | |
| CN108290948A (zh) | 抗-cd47抗体及使用方法 | |
| EP4292611A1 (en) | Anti-cd112r antibody and use thereof | |
| US20100092455A1 (en) | Novel anti-proliferation antibodies | |
| CN113474362A (zh) | 对cd44特异性的抗体 | |
| RU2754760C2 (ru) | Водная фармацевтическая композиция анти-il17a антитела и ее применение | |
| JP7578289B2 (ja) | Ｍｕｃ１８に特異的な抗体 | |
| KR102500845B1 (ko) | 항-tigit 항체 및 이의 용도 | |
| WO2020098672A1 (zh) | 一种融合蛋白及其用途 | |
| CN116262790A (zh) | 嵌合的抗cd27抗体组合物及其应用 | |
| WO2023093831A1 (zh) | 包含SIRPα突变体的融合蛋白 | |
| WO2023045859A1 (zh) | Cd38单克隆抗体及其应用 | |
| CN119584995A (zh) | 组合疗法 | |
| EP4549466A1 (en) | Development and use of novel multispecific tumor inhibitor | |
| HK40120136A (zh) | 针对警报素的双特异性结合蛋白及其用途 | |
| WO2025182946A1 (ja) | 肥満細胞が病態を増悪させる疾患の治療及び／又は予防用医薬組成物 | |
| KR20260013464A (ko) | 항-콜로니 자극 인자 1 수용체 항체를 이용한 만성 이식편대숙주 질환-관련 폐쇄성 세기관지염 증후군의 치료 방법 | |
| NZ791361B2 (en) | Engineered anti-il-2 antibodies | |
| HK40029982B (en) | Antibodies binding human claudin 18.2 and uses thereof |